Molecules/LIRILUMAB

LIRILUMAB

Molecular Identity

AntibodyPhase 2

Mechanism of action: Killer cell immunoglobulin-like receptor 2DL1 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

Anti-KIR AntibodyBMS-986015BMS-986015-01BMS-98601501IPH-2102IPH2102LIRILUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to LIRILUMAB

Loading drug network...